Vascular Solutions (VASC) Tops Q3 EPS by 2c; Boosts FY15 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- CAE agrees to sell Flightscape unit to SITA for $500 million
Vascular Solutions Reports Third Quarter Results
October 20, 2015 4:05 PM EDTRevenue increased 16% to $37 million, matching the top end of guidanceAdjusted EPS of $0.27 exceeded the top end of guidance; GAAP EPS of $0.16Raising 2015 revenue guidance to $146 - $147 million, representing an increase of 16% at the midpointRaising 2015 adjusted EPS guidance to $1.03 - $1.05
MINNEAPOLIS, Oct. 20, 2015 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq: VASC) today reported financial results for the third quarter ended September 30, 2015.
Worldwide revenue increased 16% from the third quarter of 2014 to $37.0 million, which matched the top end of... More



